Medicine
Genetic Counseling and Testing for Lynch Syndrome
Quick fact
Lynch syndrome is the most common hereditary cause of colorectal cancer, accounting for about 2-4% of all cases, and it increases the lifetime risk of colorectal cancer to up to 80% if not managed. Yet, many carriers are unaware, and genetic testing can identify them before cancer occurs, enabling life-saving surveillance.
Why this is interesting
You might have heard that some cancers run in families, but what if we could look at your DNA to see your exact inherited risk and then do something about it? For Lynch syndrome, we can — and the process is a powerful blend of science and counseling.
Read the full explanation
Understanding Genetic Counseling and Testing for Lynch Syndrome
Think of your DNA as the instruction manual for your cells. Some genes are like proofreaders; they catch and fix mistakes when DNA is copied. In Lynch syndrome, one of these proofreader genes (like MLH1, MSH2, MSH6, or PMS2) has a typo, making it less effective. As a result, errors accumulate, especially in cells that divide rapidly, like the lining of the colon or uterus. This increases the chance of cancer. Genetic counseling is the first step. It is a conversation with a specialist who explains what Lynch syndrome is, what the test can and cannot tell you, and how the results might affect you and your family. The counselor also takes a detailed family history to see if patterns match (e.g., several relatives with colorectal or endometrial cancer at young ages). If testing is decided, it usually starts with a blood or saliva sample from someone in the family who has had cancer. You look for a mutation in one of the mismatch repair genes. If found, then other relatives can be tested for that exact mutation. This is called 'cascade testing.' Your result = your personal risk map. A positive test does not mean you will get cancer, but it tells you that you have a high lifetime risk, often over 50%. That information allows for proactive measures: starting colonoscopies at age 20-25, every 1-2 years, and for women, endometrial biopsies and consideration of risk-reducing surgery. The counseling part helps you digest the information, cope with the emotional impact, and communicate with family members who may also be at risk. Genetic testing for Lynch syndrome is not just about you; it is about your whole family tree.
A deeper explanation
The mechanism behind Lynch syndrome lies in DNA mismatch repair (MMR). Every time a cell divides, it copies its DNA. Despite proofreading by DNA polymerases, errors slip through. The MMR system catches these errors, excises the wrong segment, and resynthesizes it correctly. Lynch syndrome is caused by a germline mutation in one MMR gene (MLH1, MSH2, MSH6, PMS2) or in EPCAM which turns off MSH2. With one defective allele, the cell still has a working copy, so mistakes are usually corrected early. But if a 'second hit' inactivates the working allele (as often happens in colon or endometrial cells), the MMR system is effectively lost. Now errors accumulate rapidly, especially in repetitive DNA sequences called microsatellites, leading to 'microsatellite instability' (MSI). MSI is a hallmark of Lynch tumors and helps diagnose the syndrome. Inherited mutations are autosomal dominant, meaning a person has a 50% chance to pass it on to each child. Penetrance is high but not complete—carriers have a 40-80% lifetime risk of colorectal cancer and 40-60% risk of endometrial cancer, along with increased risks of ovarian, stomach, and other cancers. Genetic testing identifies the specific mutation. The test typically uses next-generation sequencing to scan the entire gene for pathogenic variants, plus deletion/duplication analysis. If a mutation is found, the clinical diagnosis is confirmed, and the risk can be quantified with known disease-associated mutations. Why does this matter? Because knowledge changes outcomes. A mutation carrier who undergoes regular surveillance can reduce their colorectal cancer risk by 60% because polyps are removed before they become malignant. For women, risk-reducing hysterectomy and bilateral salpingo-oophorectomy can reduce endometrial and ovarian cancer risk dramatically. Genetic counseling ensures that this information is delivered with support, and it helps relatives understand their options before symptoms appear. Without testing, carriers might only be diagnosed after cancer develops. With testing, we can intervene before cancer, fulfilling the promise of precision medicine.